66 related articles for article (PubMed ID: 7948319)
21. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
22. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
23. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
[TBL] [Abstract][Full Text] [Related]
25. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis].
Lauritsen K; Laursen LS; Madsen JR
Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093
[No Abstract] [Full Text] [Related]
26. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
[TBL] [Abstract][Full Text] [Related]
27. The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats.
Min YS; Yim SH; Bai KL; Choi HJ; Jeong JH; Song HJ; Park SY; Ham I; Whang WK; Sohn UD
Auton Autacoid Pharmacol; 2005 Jul; 25(3):85-91. PubMed ID: 15955027
[TBL] [Abstract][Full Text] [Related]
28. [Comment on the contribution: "Effect of omeprazole on serum gastrin levels: influence of age and sex" by Koop et al].
Miederer SE
Z Gastroenterol; 1991 Apr; 29(4):177-8. PubMed ID: 1866976
[No Abstract] [Full Text] [Related]
29. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245.
Wandall JH
Gut; 1992 May; 33(5):617-21. PubMed ID: 1319381
[TBL] [Abstract][Full Text] [Related]
30. [Omeprazole: a step forward in the therapy of acido-peptic disease].
Piqué JM
Med Clin (Barc); 1992 Jun; 99(5):179-82. PubMed ID: 1507897
[No Abstract] [Full Text] [Related]
31. [A meeting of experts in Washington. Omeprazole: important progress in the treatment of gastric pathology. Activity and cicatrization rate in ulcer are highlighted].
Rev Clin Esp; 1989; 185(3):suppl 2p.. PubMed ID: 2623222
[No Abstract] [Full Text] [Related]
32. Omeprazole and neutrophil function.
Shamburek RD; Ruddy S; Schubert ML
Gastroenterology; 1993 Mar; 104(3):938-40. PubMed ID: 8382648
[No Abstract] [Full Text] [Related]
33. The safety of omeprazole: true or false?
Sachs G
Gastroenterology; 1994 May; 106(5):1400-1. PubMed ID: 8174907
[No Abstract] [Full Text] [Related]
34. The effect of omeprazole on human natural killer cell activity.
Aybay C; Imir T; Okur H
Gen Pharmacol; 1995 Oct; 26(6):1413-8. PubMed ID: 7590140
[TBL] [Abstract][Full Text] [Related]
35. [Bullous pemphigoid secondary corticoresistant. Inhibitory role of omeprazole on corticosteroid metabolism?].
Chosidow O; Joly P; Laurent-Puig P; Prost C; Espagne E; Wechsler J; Roujeau JC; Revuz J
Ann Dermatol Venereol; 1991; 118(1):45-6. PubMed ID: 2018306
[No Abstract] [Full Text] [Related]
36. Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
Campo N; Alvarez S; Borzone S; Caglieris S; Zentilin P; Testa R
Am J Gastroenterol; 1994 Aug; 89(8):1271-2. PubMed ID: 8053457
[No Abstract] [Full Text] [Related]
37. [Advances in the knowledge of peptic-acid dependent diseases].
Mazure PA; Pigliacampo J
Acta Gastroenterol Latinoam; 1989; 19(3):165-73. PubMed ID: 2576850
[No Abstract] [Full Text] [Related]
38. Conventional dose of omeprazole alters gastric flora.
Karmeli Y; Stalnikowitz R; Eliakim R; Rahav G
Dig Dis Sci; 1995 Sep; 40(9):2070-3. PubMed ID: 7555466
[TBL] [Abstract][Full Text] [Related]
39. [Omeprazole: chemical structure and mode of action].
Med Clin (Barc); 1990 Feb; 94(4):suppl 2p.. PubMed ID: 2325461
[No Abstract] [Full Text] [Related]
40. [Reduced ex vivo production of superoxide anion by polymorphonuclear leukocytes during therapy with omeprazole. A pharmacological effect?].
Capodicasa E; Ciaccio V; Corazzi F; De Bellis F; Bucaneve G; Ficola F; Pelli MA
Minerva Gastroenterol Dietol; 1994 Sep; 40(3):105-11. PubMed ID: 7948319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
